Pierre Michel
Overview
Explore the profile of Pierre Michel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
143
Citations
6775
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Grancher A, Beaussire-Trouvay L, Vernon V, Dutherage M, Blondin V, Elie C, et al.
Br J Cancer
. 2025 Mar;
PMID: 40089635
Background: Circulating tumor DNA variations (∆ctDNA) were reported to be associated with treatment efficacy in metastatic colorectal cancer (mCRC). The present study evaluated ∆ctDNA according to first-line treatment intensity. Methods:...
2.
Guller U, Hayoz S, Horber D, Jochum W, De Dosso S, Koeberle D, et al.
Clin Cancer Res
. 2025 Mar;
PMID: 40067142
Purpose: We assessed the benefit of adjuvant aspirin in resected PIK3CA-mutated colon cancer patients. Patients & Methods: This was a phase III, prospective, randomized, placebo-controlled, double-blind, multicenter, and multinational trial....
3.
Ngo N, Michel P, Giorgi R
BMC Med Res Methodol
. 2024 Dec;
24(1):307.
PMID: 39702003
Background: The -metric value is generally used as the importance score of a feature (or a set of features) in a classification context. This study aimed to go further by...
4.
Cascarano L, Esfahani H, Michel P, Bouzin C, Dessy C, Balligand J, et al.
Physiol Genomics
. 2024 Jul;
56(10):649-660.
PMID: 39007510
The prevalence of metabolic syndrome in cardiac diseases such as heart failure with preserved ejection fraction (HFpEF) prompts the scientific community to investigate its adverse effects on cardiac function and...
5.
Hoba J, Grancher A, Hautefeuille V, Turpin A, Bouhier-Leporrier K, Galais M, et al.
Dig Liver Dis
. 2024 Jun;
57(1):30-37.
PMID: 38851974
Purpose: Relative dose intensity (RDI) is a measurement of chemotherapy (CT) dose defined as the actual dose received divided by the standard calculated dose during a set period. The study...
6.
Gronnier C, Mariette C, Lepage C, Monterymard C, Jary M, Ferru A, et al.
Cancers (Basel)
. 2023 Apr;
15(7).
PMID: 37046849
Purpose: While perioperative chemotherapy provides a survival benefit over surgery alone in gastric and gastroesophageal junction (G/GEJ) adenocarcinomas, the results need to be improved. This study aimed to evaluate the...
7.
Grancher A, Beaussire L, Manfredi S, Le Malicot K, Dutherage M, Verdier V, et al.
Front Oncol
. 2022 Nov;
12:973167.
PMID: 36439476
Circulating tumor DNA (ctDNA) is reported to be promising in localized colorectal cancer (CRC). The present study aimed to retrospectively evaluate the impact of ctDNA in patients with a resected...
8.
Systematic Review of In Vitro Antimicrobial Susceptibility Testing for Bacillus anthracis, 1947-2019
Maxson T, Kongphet-Tran T, Mongkolrattanothai T, Travis T, Hendricks K, Parker C, et al.
Clin Infect Dis
. 2022 Oct;
75(Suppl 3):S373-S378.
PMID: 36251548
Bacillus anthracis, the causative agent of anthrax, is a high-consequence bacterial pathogen that occurs naturally in many parts of the world and is considered an agent of biowarfare or bioterrorism....
9.
Lepage C, Phelip J, Lievre A, Le-Malicot K, Dahan L, Tougeron D, et al.
Eur J Cancer
. 2022 Sep;
175:31-40.
PMID: 36087395
Background: Following European guidelines, patients with aggressive metastatic or locally advanced, non-resectable, duodeno-pancreatic (DP) neuroendocrine tumours (NETs) should receive systemic combination chemotherapy until progression. Aggressive disease is defined as progressive...
10.
Grancher A, Michel P, Di Fiore F, Sefrioui D
Cancer Biol Ther
. 2022 Jul;
23(1):446-461.
PMID: 35905195
Screening strategies have demonstrated their potential for decreasing the incidence and mortality of cancers, particularly that of colorectal cancer (CRC). Another strategy that has been developed to reduce CRC occurrence...